Literature DB >> 10831252

Centrally produced nitric oxide and the regulation of body fluid and blood pressure homeostases.

M Kadekaro1, J Y Summy-Long.   

Abstract

1. Nitric oxide (NO) tonically inhibits the basal release of vasopressin and oxytocin into plasma. 2. Nitric oxide inhibition on vasopressin secretion is removed, while that on oxytocin is enhanced, during water deprivation, hypovolaemia, moderate osmotic stimulation and angiotensin (Ang)II. This results in a preferential release of vasopressin over oxytocin that promotes conservation of water. 3. Nitric oxide facilitates drinking behaviour stimulated by water deprivation, osmotic stimulation, haemorrhage and AngII. Together with the hormonal response, NO produces a positive water balance during reductions in intracellular and intravascular volumes. 4. Nitric oxide produced within the central nervous system maintains resting arterial blood pressure partially by attenuating the pressor actions of AngII and prostaglandins. 5. Central production of NO is enhanced during osmotic stimulation to counterbalance the salt-induced pressor response. 6. Paradoxically, central production of NO is also enhanced during haemorrhage, presumably to maintain peripheral vasodilation and blood flow to vital organs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831252     DOI: 10.1046/j.1440-1681.2000.03264.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

1.  Effect of NMDA-induced lesion of the subfornical organ on the angiotensin II binding sites density and acetylcholinesterase or NADPH-diphorase activities in the lamina terminalis of the rat brain.

Authors:  S S Guilhaume; F M Corrêa
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

2.  Augmented central nitric oxide production inhibits vasopressin release during hemorrhage in acute alcohol-intoxicated rodents.

Authors:  Annie M Whitaker; Jesse K Sulzer; Patricia E Molina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-17       Impact factor: 3.619

3.  Cellular sources, targets and actions of constitutive nitric oxide in the magnocellular neurosecretory system of the rat.

Authors:  Javier E Stern; Wenfeng Zhang
Journal:  J Physiol       Date:  2004-11-18       Impact factor: 5.182

4.  Central nitrergic system regulation of neuroendocrine secretion, fluid intake and blood pressure induced by angiotensin-II.

Authors:  Wagner L Reis; Wilson A Saad; Luiz A Camargo; Lucila Lk Elias; José Antunes-Rodrigues
Journal:  Behav Brain Funct       Date:  2010-10-25       Impact factor: 3.759

5.  Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus.

Authors:  C G Coleman; J Anrather; C Iadecola; V M Pickel
Journal:  Neuroscience       Date:  2009-06-17       Impact factor: 3.590

6.  Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension.

Authors:  Thiago Santos Moreira; Ana Carolina Thomaz Takakura; José V Menani; Monica Akemi Sato; Eduardo Colombari
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

7.  Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.

Authors:  Baojian Xue; Minati Singh; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

8.  Genetic risk variants for metabolic traits in Arab populations.

Authors:  Prashantha Hebbar; Naser Elkum; Fadi Alkayal; Sumi Elsa John; Thangavel Alphonse Thanaraj; Osama Alsmadi
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 9.  Effects of nitric oxide on magnocellular neurons of the supraoptic nucleus involve multiple mechanisms.

Authors:  M P da Silva; P L Cedraz-Mercez; W A Varanda
Journal:  Braz J Med Biol Res       Date:  2014-01-17       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.